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We sought to compare operator radiation exposure during procedures using right femoral 
access (RFA), right radial access (RRA), and left radial access (LRA) during coronary 
angiography (CA) and percutaneous coronary intervention (PCI). Because of an increased 
incidence of long-term malignancy in interventional cardiologists, operator radiation 
exposure is of rising concern. This prospective study included all consecutive patients who 
underwent elective or emergency CA – PCI from September 2014 to March 2015. The 
primary end point was operator radiation exposure, quantiﬁed as the ratio of operator 
cumulative dose (CD) and patient radiation reported as dose-area product (DAP)
(CD/DAP). Secondary end points included CD, DAP, and ﬂuoroscopy time (FT). Overall 
830 procedures (457 CA [55%] and 373 PCI [45%]) were performed, 455 (55%) through 
RFA, 272 (33%) through RRA, and 103 (12%) through LRA. The CD/DAP was lower in 
RFA (0.09 mSv/Gycm2 [0.02 to 0.20]) compared with RRA (0.47 mSv/Gycm2 [0.25 to 0.75], 
p <0.001). The LRA showed lower CD/DAP compared with RRA (p <0.001). CD was 
signiﬁcantly lower in RFA (3 mSv [1 to 7]) compared with RRA (12 mSv [6 to 29], p <0.001). 
The LRA showed lower CD compared with RRA (p <0.001). There were no signiﬁcant 
differences in DAP among the 3 access sites. FT was similar for the 3 groups (RFA 7 – 7, 
RRA 5 – 5, LRA 6 – 5 minutes, RFA vs RRA: p [ 1, RFA vs LRA: p [ 0.16, RRA vs LRA: 
p [ 0.52). In conclusion, the use of RFA during CA – PCI is associated with signiﬁcantly 
lower operator radiation exposure compared with RRA. LRA is associated with signiﬁ-
cantly lower operator radiation exposure compared with RRA. 
Because of a presumably increased stochastic risk of
cancer induction among interventional cardiologists, espe-
cially neoplasms of the unprotected brain, nasopharyngeal
tract, and upper extremities, operator radiation exposure
during coronary angiography (CA) and/or percutaneous
coronary intervention (PCI) is of rising concern.1,2 There-
fore, we undertook a comparison of operator radiation
exposure during right femoral access (RFA), left radial ac-
cess (LRA), and right radial access (RRA) during CA and
CA followed by ad hoc PCI in a real-world population.
Methods
From September 2014 to March 2015 at the University
and Hospital Fribourg, all consecutive procedures of elec-
tive or emergency CA and CA followed by ad hoc PCI were
prospectively considered for operator radiation exposure
measurements. Procedures were performed by 5 senior
interventional cardiologists with signiﬁcant experience
(>3,000 PCI each) in both femoral and radial access routes.
Selection of the percutaneous access site was left to the
discretion of the operator. Crossover access site procedures
were excluded. This study was part of the Catheterization
Registry Fribourg (CardioFR), which was approved by the
Ethics Committee of Canton Vaud (protocol no: 339/14).
The primary end point of the study was operator radiation
exposure, expressed as the cumulative equivalent dose (in
mSv) over the lead apron at chest level, normalized for the
patient radiation exposure (dose-area product [DAP] in
Gycm2). Secondary end points included cumulative dose
(CD), DAP, and ﬂuoroscopy time (FT).
Procedures were performed on a digital single-plane
cineangiography unit (Allura FD10; Philips Medical Sys-
tems, Hamburg, Germany) with an undertable x-ray tube
MRC20025 with a magniﬁcation factor leading to a ﬁeld of
view of 21 cm and an acquisition frequency of 15 frames/s.
All procedures were performed with respect to current
guidelines using either 5Fr or 6Fr hydrophilic sheaths.
Conventional diagnostic and guiding catheters were used.
The femoral access was achieved, under local anesthesia
with 2% rapidocain, through the anterior wall puncture of
the artery; 5Fr or 6Fr Terumo (Pinnacle; Terumo Medical,
Tokyo, Japan) introducer was placed in the femoral artery.
CA and PCI were performed according to standard practice
using catheter and drugs left to the discretion of the oper-
ator. Hemostasis was achieved using closure devices
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(Femoseal; St. Jude Medical, St. Paul, Minnesota) or
external mechanical compression (Femostop; St. Jude
Medical).
After sterile preparation and anesthesia with 2% rap-
idocain inﬁltration, radial artery was punctured with a 20-
gauge needle. A 0.021 Teﬂon-sheathed short guidewire
was inserted in the needle. A 3.2-section BD Venﬂon was
then inserted in the artery. A Terumo (Pinnacle; Terumo
Medical) 0.021 hydrophilic guidewire was advanced
through the radial and brachial artery. A 5Fr introducer was
then inserted in the radial artery. Vasodilator cocktail con-
sisting of verapamil 3 mg and enoxaparin 3,400 units was
administered after sheath insertion. Speciﬁc catheters were
used for CA and PCI. Exchange to a 6Fr sheath was possible
when technically necessary. At the end of the procedure, the
sheath was removed and an inﬂatable pressure band placed
to the access site. All radial accesses were performed at the
right side of the patient.
Operator protection was ensured with the same equip-
ment for all procedures. A leaded glass mobile panel with a
Figure 1. (A) Radioprotection equipment and materials. Image acquisition during a right radial case. (B) Although the shields are approximated as closely as
possible to minimize operator irradiation, there is still a radioprotection gap (yellow box), which is inevitably more important during right radial procedures.
Table 1
Baseline patient and procedural characteristics
RFA (N¼455) LRA (N¼103) RRA (N¼272) p-values
RFA vs. LRA RFA vs. RRA LRA vs. RRA
Patients
Age (yearsSD) 6812 6910 6512 1.00 0.02 0.05
Male 310 (68%) 71 (69%) 181 (67%) 1.00 1.00 1.00
Weight (kgSD) 8016 8018 8116 1.00 1.00 1.00
Height (mSD) 1.700.09 1.700.09 1.700.09 1.00 1.00 1.00
BMI (kg/m2SD) 275 275 285 1.00 1.00 1.00
Procedure
CA 216 (47%) 65 (63%) 176 (65%) 0.01 <0.01 1.00
CA followed by ad hoc PCI 239 (53%) 38 (37%) 96 (35%) 0.01 <0.01 1.00
Procedural time (minSD) 2019 1511 1812 0.05 1.00 0.08
Fluroscopy time (minSD) 77 55 65 0.16 1.00 0.52
Nb of cine-angiograms (nSD) 954520 659351 727300 <0.001 <0.01 <0.001
Variables are reported in numbers (%) or mean  SD.
BMI ¼ body mass index; CA ¼ coronary angiography; DAP ¼ dose area product; LRA ¼ left radial access; PCI ¼ percutaneous coronary intervention;
RFA ¼ right femoral access; RRA ¼ right radial access; SD ¼ standard deviation.
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patient contour cutout (0.5 lead equivalent; MAVIG,
Munich, Germany) was positioned at the left side of the
operator. An undertable pivot-leaded side shield (0.5-mm
lead equivalent) was mounted to the side of the table. An
additional soft lead shield was adjusted in the contour cut of
the leaded glass mobile panel to minimize radiation expo-
sure. The 37  42 cm upper-shield ﬂap (RADPAD,
Worldwide Innovations & Technologies, Inc, Kansas City,
USA) was placed over the access site in each procedure to
reduce scatter radiation (Figure 1). Additional radiation
protection materials were standardized for all operators and
included a lead apron, thyroid lead collar, and leaded
glasses. All procedures were performed from the patients’
anatomical right side.
Operator radiation was measured using individual
electronic dosimeters (DoseAware; Philips Healthcare,
Best, The Netherlands) positioned on the sternum, outside
the lead apron. The dosimeters are silicon-based semi-
conductor detectors with a dose-response between 1 mSv
and 10 Sv, in steps of 1 mSv (calibrated in ambient
equivalent dose Hp(10)) and a temporal resolution of 1
second. The following parameters were recorded for each
procedure: (1) operator CD through the use of dedicated
readout software (DoseView), measured by the individual
dosimeters; (2) FT; (3) number of cine angiograms (NC);
and (4) the DAP-normalized CD deﬁned as the dose (mSv)
received by the operator with each Gycm2 applied to the
patient (known as the exposure factor) has been advo-
cated3 and applied to our study as it isolates differences in
patient radiation among the 3 vascular access sites. Patient
radiation dose was expressed as DAP. Furthermore, radi-
ation exposure of the assistant nurse, the ﬁrst nurse on the
operator’s right side, was assessed using similar dosime-
ters, in a subgroup of consecutive procedures, with the aim
to compare radiation exposure of the operator versus
assistant nurse.
All statistical analyses were performed using dedicated
software (Stata, version 13; StataCorp LP, College Station,
Texas) at a 2-tailed signiﬁcance level of alpha <0.05.
Baseline patient and procedural characteristics, and vari-
ables assessing radiation exposure of the operator, were
compared among the 3 vascular access sites. Categorical
variables are reported as counts and percentages; continuous
variables are reported as mean and SD or as median with
25% to 75% interquartile range according to their distribu-
tion. Normality was assessed by visual inspection of histo-
grams, the computation of Q-Q plots and the Shapiro-Wilk
test. Categorical variables were compared using the
chi-square or Fisher’s exact test as appropriate. Continuous
variables were analyzed using the 1-way ANOVA or the
Wilcoxon rank-sum test according to their distribution. To
account for differences of the individual operators on radi-
ation exposure according to access site, we computed a
generalized linear model including the individual operators
as potential confounders of the overall treatment effect. To
account for multiple comparisons, p values are Bonferroni
adjusted, that is, multiplied by the number of comparisons.
Comparison of radiation exposure between the operator and
the ﬁrst assistant was assessed using the paired student’s t
test or the signed-rank Wilcoxon test according to
distribution.Ta
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Results
During September 2014 and March 2015, 849 consecu-
tive procedures for elective or emergency CA and CA
followed by ad hoc PCI were performed in our catheteri-
zation laboratory with a dedicated dosimeter for radiation
evaluation. Nineteen procedures (1.8%) were excluded
because of a crossover in access sites. No patient was
excluded because of lesion or procedural complexity.
Finally, 830 consecutive procedures were included in the
trial, 457 CA alone (55%) and 373 CA followed by ad hoc
PCI (45%). With regard to vascular site, 455 procedures
(55%) were carried out using the RFA, 103 (12%) using the
LRA, and 272 (33%) using the RRA. Baseline patient
characteristics were generally well balanced and depicted in
Table 1. Analysis of procedural characteristics as listed in
Table 1 revealed no difference in FT among the groups and
showed a signiﬁcantly greater NC in RFA compared with
LRA and RRA group and in RRA compared with the LRA
group, probably reﬂecting higher procedural complexity.
The radiation exposure of the assistant nurse standing at
the operator’s right side was also assessed in a subgroup of
ﬁrst 293 consecutive procedures, 152 CA alone (52%) and
141 CA followed by ad hoc PCI (48%), 164 (56%)
through RFA, 49 (17%) through LRA, and 80 (27%)
through RRA.
Table 2 and Figure 2 list patient and operator radiation
exposure. Adjusted CD was signiﬁcantly lower in RFA
compared with RRA but not to LRA. CD was lower for
procedures using LRA than RRA. Patient radiation dose
expressed by DAP did not signiﬁcantly vary among the 3
access sites. Operator radiation dose reported as the DAP-
normalized CD was signiﬁcantly higher in the RRA
compared with the RFA and LRA group for all pro-
cedures, procedures with CA alone, and procedures with
CA followed by ad hoc PCI. There were no signiﬁcant
differences between the RFA and the LRA for any kind of
procedure. Table 3 indicates DAP, CD, and DAP-
normalized CD for the individual operators. A signiﬁ-
cantly higher radiation exposure comparing the RRA with
the RFA was consistently found for all operators. Signif-
icant differences in radiation exposure between RFA and
LRA and RRA and LRA were found only for 2 of the 5
operators. Radiation exposure for elective and urgent
procedures is provided in Table 4. During elective pro-
cedures, radiation exposure was lower for RFA compared
with RRA, but not to LRA. However, LRA showed a
lower DAP-normalized CD compared with RRA
(p <0.001). In addition to the aforementioned differences,
LRA was associated with a higher radiation exposure
than RFA, when only urgent procedures were considered
Figure 2. Operator CD, patient radiation dose (DAP), operator radiation exposure (CD/DAP), and FT for all procedures: CA and CA followed by ad hoc PCI.
Columns: 3 vascular access sites in percentiles (colors): black: 0 to 25th, blue: 26 to 50th, red: 51 to 75th, and beige: 76 to 100th, median values on the board of
blue and red columns.
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(p <0.01). In the subgroup of the ﬁrst consecutive 293
procedures, operator exposure was signiﬁcantly higher
compared with the assistant nurse’s as listed in Table 5 for
all procedures and by access site.
Discussion
The main ﬁndings of the current prospective trial are the
following: (1) interventional Cardiologists are exposed to a
lower degree of radiation when performing CA or CA fol-
lowed by ad hoc PCI through the RFA rather than the RRA;
(2) interventional cardiologists are exposed to a lower
degree of radiation when performing CA or CA followed by
ad hoc PCI using the LRA rather than the RRA; and (3) the
operator is more exposed to radiation compared with the
assistant nurse standing at his right side during the
procedures.
Transradial cardiac catheterization is known to be asso-
ciated with an increased operator radiation dose even for
highly experienced interventional cardiologists and despite
the use of radioprotection optimization techniques.4e9 Data
are limited with regard to operator radiation exposure when
right and left radial accesses are compared,10e13 with most
investigators reporting lower radiation levels for LRA, alike
Table 3
Radiation exposure according to the individual operator
RFA LRA RRA p-values
RFA vs. LRA RFA vs. RRA LRA vs. RRA
CA andCA followed by ad hoc PCI
Operator 1 N¼39 N¼77 N¼88
DAP (Gycm2) 31 (20-59) 28 (17-41) 32 (19-55) 0.28 1.00 0.16
CD (mSv) 9 (4-15) 6 (4-11) 15.5 (8-33) 0.08 <0.01 <0.001
CD/DAP (mSv/Gycm2) 0.28 (0.16-0.44) 0.23 (0.14-0.35) 0.51 (0.37-0.84) 0.33 <0.001 <0.001
Operator 2 N¼132 N¼3 N¼28
DAP (Gycm2) 44 (31-90) 67 (37-90) 36 (18-56) 1.00 0.07 0.20
CD (mSv) 1 (0-2) 1 (0-3) 1 (0.5-7.5) 1.00 <0.01 1.00
CD/DAP (mSv/Gycm2) 0.01 (0-0.04) 0.01 (0.00-0.04) 0.05 (0.00-0.17) 1.00 <0.01 0.53
Operator 3 N¼98 N¼1 N¼3
DAP (Gycm2) 36 (21-67) 73 135 (14-166) 0.73 0.60 1.00
CD (mSv) 4 (2-10) 7 87 (25-484) 1.00 <0.01 0.02
CD/DAP (mSv/Gycm2) 0.10 (0.05-0.19) 0.09 1.78 (0.64-2.90) 1.00 <0.01 0.36
Operator 4 N¼139 N¼12 N¼69
DAP (Gycm2) 30 (17-54) 36 (24-128) 33 (22-50) 0.23 0.49 0.82
CD (mSv) 4 (1-6) 1.5 (1-3.5) 12 (7-36) 0.16 <0.001 <0.001
CD/DAP (mSv/Gycm2) 0.10 (0.05-0.18) 0.05 (0.01-0.08) 0.45 (0.24-0.78) <0.01 <0.001 <0.001
Operator 5 N¼47 N¼10 N¼84
DAP (Gycm2) 35 (21-51) 27 (14-49) 30 (17-47) 0.92 0.40 1.00
CD (mSv) 7 (4-13) 12 (11-37) 12 (8-28) 0.04 <0.001 0.81
CD/DAP (mSv/Gycm2) 0.21 (0.12-0.35) 0.59 (0.44-1.43) 0.48 (0.32-0.72) <0.01 <0.001 0.55
Values are reported in medians (interquartile range: P25 to P75).
CA ¼ coronary angiography; CD ¼ cumulative dose; DAP ¼ dose area product; LRA ¼ left radial access; PCI ¼ percutaneous coronary intervention;
RFA ¼ right femoral access; RRA ¼ right radial access; SD ¼ standard deviation.
Table 4
Radiation exposure of the operator and patient stratiﬁed by operator
RFA LRA RRA Crude p-values Adjusted p-values
RFA vs.
LRA
RFA vs.
RRA
LRA vs.
RRA
RFA vs.
LRA
RFA vs.
RRA
LRA vs. RRA
CA and CA followed by ad hoc PCI
Elective N¼285 N¼90 N¼206
DAP (Gycm2) 34 (21-57) 32 (19-48) 31 (19-50) 0.37 0.41 1.00 0.77 0.35 0.72
CD (mSv) 3 (1-6) 6 (3-12) 11 (6-25) <0.001 <0.001 <0.001 0.36 <0.001 <0.01
CD/DAP (mSv/Gycm2) 0.09 (0.03-0.20) 0.22 (0.12-0.35) 0.43 (0.23-0.72) <0.001 <0.001 <0.001 0.13 <0.001 <0.001
Urgent N¼170 N¼13 N¼66
DAP (Gycm2) 41 (25-84) 25 (12-44) 38 (21-57) 0.02 0.11 0.29 0.69 0.62 0.16
CD (mSv) 3 (1-10) 4 (1-6) 17.5 (8-41) 1.00 <0.001 <0.001 <0.01 <0.001 0.001
CD/DAP (mSv/Gycm2) 0.08 (0.02-0.19) 0.15 (0.10-0.21) 0.55 (0.37-0.85) 0.16 <0.001 <0.001 <0.01 <0.001 <0.001
Values are reported in medians (interquartile range: P25 to P75).
CA ¼ coronary angiography; CD ¼ cumulative dose; DAP ¼ dose area product; LRA ¼ left radial access; PCI ¼ percutaneous coronary intervention;
RFA ¼ right femoral access; RRA ¼ right radial access; SD ¼ standard deviation.
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to initial scientiﬁc concerns and despite the operator’s
inconvenience when leaning over to reach the patient’s left
side. To our knowledge, this is the ﬁrst single-center trial to
compare operator radiation exposure among these 3 vascular
access sites for CA and CA followed by ad hoc PCI.
Recently, the Randomized Evaluation of Vascular Entry
Site and Radiation Exposure trial14 evaluated patient and
operator radiation exposure among the 3 access sites RFA,
LRA, and RRA and included only CA procedures without
CA followed by ad hoc PCI procedures. It reported higher
operator radiation for LRA using air kerma as primary end
point, which is not the ideal patient exposure metric,
although also analyzing DAP as a secondary end point and
found an FT much shorter than our study’s, presumably
because PCIs were excluded. Furthermore, the population
included in the Randomized Evaluation of Vascular Entry
Site and Radiation Exposure trial shows a median weight
and height of 64 to 65 kg and 163 to 164 cm, respectively,
resulting subsequently in lower DAP values (in the order of
26 Gycm2 per procedure).
Both procedure-related and operator-related factors
appear responsible for the differences in operator radiation
exposure per vascular access site. It has been reported that
increased operator radiation exposure during radial access,
as opposed to femoral access, is related to increase in FT,
reﬂecting technical difﬁculties and to the slightly closer
operator’s position to the x-ray tube and to the patient,
compared with femoral access.5,15,16 In contrast, decreased
operator radiation dose and shorter FT have been reported
when using LRA compared with RRA.10,11,17e20 In our
study, there are some details in radiation protection tech-
niques that should be taken into consideration: First, during
RRA procedures, the leaded glass mobile panel is positioned
less proximally to the table compared with LRA and RFA to
facilitate the right radial access. The radioprotection gap
which is inevitably created between the leaded glass mobile
panel and the patient table is more pronounced during RRA
procedures, thus creating a considerable source of radiation
exposure to the operator (Figure 1). Second, when using
RRA, the operator is positioned closer to the x-ray tube and
closer to the patient compared with both LRA and RFA
procedures, increasing the effect of the patient as the main
source of scatter radiation to the operator. Furthermore,
technical challenges in maneuvering catheters into the cor-
onary vessels can lead in longer FT. In particular, the
vascular anatomy associated with the right radial artery,
including the right subclavian artery-common brachioce-
phalic trunk bifurcation and the common brachiocephalic
trunk-aorta bifurcation, could account for tortuosity and
calciﬁcations that could impair procedural success. In
considering the left radial artery, the left subclavian artery
stems directly from the aortic arch, thus reducing the tech-
nical challenges in catheter manipulation, whereas in the
right femoral artery there is no such issue at all. Finally,
further technical difﬁculties associated with radial artery
access include spasm or tortuosity of the radial artery, which
could increase ﬂuoroscopy and procedure times. Nonethe-
less, in our study, FT did not differ signiﬁcantly among the 3
access sites, suggesting a high level of operator experience
across the 3 groups. On the contrary, the longer procedural
times and the greater NC in the femoral group reﬂect a
higher complexity of procedures being performed through
this access, while still beneﬁtting from decreased operator
radiation exposure compared with the 2 radial groups.
The present study conﬁrms the greater radiation exposure
of the operator compared with the ﬁrst assistant who is
standing at his right side, regardless of the vascular access site.
This is expected because of the nurse’s greater distance from
the source of radiation and from the patient. Most authors
studying operator radiation dose issues report results
normalized per procedure and not per-patient radiation dose
measured as DAP. This means that whether the dose is higher
for femoral or radial approach will be a result of both the
higher or lower DAP (and FT), the distance effect, and radi-
ation protection aspects. If the dose is normalized per DAP,
one can isolate, to a certain extent, the ﬁrst 2 issues, and the
results will then be mostly related to the radiation protection
level and the distance between operator and patient.21 Our
results in terms of procedure (ﬂuoroscopy and procedural
times) and radiation dose of the operator (CD) and the patient
(DAP) are in line with published data in the literature.
Although not randomized, the present study reﬂects operator
radiation exposure in a real-world population in everyday
clinical practice, despite a bias in the choice of vascular access
site by the operator. Furthermore, the 3 groups were ho-
mogenous with regard to characteristics that inﬂuence oper-
ator and patient irradiation such as patients’ body mass index
and procedural and FTs, thus reﬂecting a representative
sample of a real-world population without exclusion of
emergent or complex procedures. The greater NC in the RFA
group compared with the LRA and RRA groups and in the
RRA compared with the LRA group probably suggests
increased procedural complexity and could be reﬂected in the
higher patient irradiation (DAP) in the RFA group compared
with the 2 radial groups. The normalization, however, of the
operator irradiation for patient irradiation takes into consid-
eration such parameters as procedural complexity and patient
corpulence, thus accurately reﬂecting the actual operator ra-
diation dose, and is dependent only on the following 2 pa-
rameters: (1) the degree of radioprotection itself and (2) the
distance between patient and operator. Therefore, interpreta-
tion of results using the DAP-normalized operator radiation
Table 5
Comparison of radiation exposure between operator and assistant nurse
CA and CA followed by
ad hoc PCI (N¼293)
Operator Assisstant nurse p-value
DAP (Gycm2) 32 (20-53) 32 (20-53) 1.00
CD (mSv) 5 (1-13) 2 (1-5) <0.001
CD/DAP (mSv/Gycm2) 0.16 (0.04-0.46) 0.07 (0.03-0.13) <0.001
RFA (N¼164)
CD/DAP (mSv/Gycm2) 0.06 (0.01-0.18) 0.06 (0.03-0.11) <0.05
LRA (N¼49)
CD/DAP (mSv/Gycm2) 0.23 (0.10-0.45) 0.06 (0.04-0.10) <0.001
RRA (N¼80)
CD/DAP (mSv/Gycm2) 0.51 (0.32-0.81) 0.10 (0.06-0.17) <0.001
Values are reported in medians (interquartile range: P25 to P75).
CA ¼ coronary angiography; CD ¼ cumulative dose; DAP ¼ dose area
product; LRA ¼ left radial access; PCI ¼ percutaneous coronary inter-
vention; RFA ¼ right femoral access; RRA ¼ right radial access; SD ¼
standard deviation.
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dose allows for isolation and meaningful evaluation of tech-
nical differences among the 3 vascular access sites based on
the positioning of radioprotection equipment, the operator’s
position, and his distance from the patient and the x-ray tube.
This was a nonrandomized, single-center study.
Therefore, these results have to be interpreted with caution
for other catheterization laboratories because of possible
differences in operator experience, training and techniques,
radioprotection materials, and devices. Furthermore,
procedures were performed by 5 different, although highly
experienced, interventional cardiologists implicating differ-
ences in catheterization techniques, procedural and FTs,
NC, and thus effecting individual radiation dose. Finally, in
our study, operator dose was measured by 1 single
dosimeter positioned externally to the sternum, with no
possibility to measure and compare radiation exposure of
other corporal areas.
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